Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
C. Mamoun, A. C. Pal, I. Renard…·J. S. Doggett
This paper establishes a new in vitro and in vivo model using Babesia duncani to study parasite development, virulence, and drug susceptibility, identifying effective new therapies.
J. E. Chiu, I. Renard, A. Chattopadhyay Pal…·C. Ben Mamoun
This study identifies an effective ELQ prodrug that prevents Babesia erythrocytic development and protects against lethal infection in mouse models.
J. S. Doggett, T. L. Schultz, A. Miller…·V. B. Carruthers
This study develops an orally bioavailable prodrug of ELQ-316 that enhances its plasma concentrations and efficacy against Toxoplasma gondii infection.
M. J. Smilkstein, S. Pou, A. Krollenbrock…·M. K. Riscoe
This paper evaluates ELQ-331 as a long-acting injectable chemoprotective agent against malaria, showing it provides durable protection in mice for up to 4.5 months.